1-1 of 1
Wouter J. Kollen
Close
Sort by
Journal Articles

Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen

Clinical Trials & Observations
A. Birgitta Versluijs, Coco C. H. de Koning, Arjan C. Lankester, Stefan Nierkens, Wouter J. Kollen, Dorine Bresters, Caroline A. Lindemans, Jaap Jan Boelens, Marc Bierings
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1719–1730.
https://doi.org/10.1182/bloodadvances.2021005224
Published: 2022
Includes: Supplemental data